Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive…
With 30 years of international leadership experience in the MedTech sector across Europe and the U.S., Vincent brings deep expertise in commercial strategy, market expansion, and value creation. He has successfully guided several companies through critical phases of growth and commercialization, including his tenure as CEO of Vexim, where he transformed the spinal implant company from an early-stage venture into a profitable international organization, ultimately leading to a successful IPO and…
PR Newswire
06/11/2025
Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery…
Understanding the challenges of early-stage development, Mabqi and Abzena formed their partnership to offer a solution that enables drug developers to seamlessly bridge from discovery through lead candidate selection into pre-clinical development and beyond. Through this collaboration, customers will benefit from combined scientific and technical support, streamlined workflows, and accelerated development timelines. Understanding the challenges of early-stage development, Mabqi and Abzena...
PR Newswire
06/11/2025
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to…
The two Groups have reached a binding agreement on the main principles of their collaboration, with a view to deploying a capacity of one million tonnes in the long term,Starting with the construction of a plant in China with a processing capacity of 50,000 tonnes of PET waste per year.This collaboration remains subject to the signing of final agreements.Clermont-Ferrand (France), November 6, 2025 (08:30am CET).Following the Letter of intent signed on June 24, 2024, CARBIOS...
Nasdaq GlobeNewswire
06/11/2025
Kanazawa University research: Protein droplets in the nucleus guard against…
Our genetic material is tightly packed inside the cell nucleus, wrapped around proteins called histones. To keep the right genes active, cells rely on proteins like CHD1, which reorganize this DNA structure when needed. Our genetic material is tightly packed inside the cell nucleus, wrapped around proteins called histones. To keep the right genes active, cells rely on proteins like CHD1, which reorganize this DNA structure when needed. The Kanazawa team led byKatsuya Sakai, discovered...
PR Newswire
06/11/2025
Lunai Bioworks achieves complete regression of both primary and metastatic…
The study was published in a new Brief Report in Vaccines on November 2, 2025. The peer-reviewed Brief Report details the development of a second-generation, clinical-grade DC construct that achieved complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models. Pancreatic cancer is one of the deadliest cancers, often diagnosed late and resistant to conventional treatments. Lunai's therapy uses engineered dendritic cells — specialized immune cells created…
PR Newswire
06/11/2025
8% organic sales growth after first nine months. Full-year organic sales growth…
Ester Baiget, President & CEO:” I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all sales areas and in Emerging and Developed Markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds, demonstrating the strength and resilience of our business model. Following a robust nine-months performance including favorable timing in the...
Nasdaq GlobeNewswire
06/11/2025
HSG Laser Unveils Smart Sheet & Tube Cutting Solutions at SMTECH 2025
At Booth 321, Tüyap Fair and Congress Center, HSG LASER showcased flagship machines that highlight its innovation in intelligent laser cutting — combining speed, precision, and automation to elevate industrial efficiency. At Booth 321, Tüyap Fair and Congress Center, HSG LASER showcased flagship machines that highlight its innovation in intelligent laser cutting — combining speed, precision, and automation to elevate industrial efficiency. BridgingEuropeandAsia : Empowering Smart...
PR Newswire
06/11/2025
Interim Report Q3 2025: Solid quarter with 1% organic growth, 11% EBITA margin…
HighlightsThe Hearing division delivered 7% organic revenue growth driven by the continued strong performance of ReSound Vivia, enabling broad-based market share gains. The divisional profit margin ended at 34%, driven by positive operating leverage, but partly offset by negative country mixThe Enterprise division continued to experience positive sell-out growth outside of Europe, driven by strong channel execution and market leading innovation, while Europe continued to be challenged...
Nasdaq GlobeNewswire
06/11/2025
Pharming Group reports third quarter 2025 financial results with significant…
Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth in patients and prescribersJoenja® (leniolisib) third quarter revenue increased by 35% to US$15.1 million, compared to third quarter 2024, reflecting strong growth in patients on therapy FDA granted priority review of sNDA for leniolisib...
Nasdaq GlobeNewswire
06/11/2025
138th Canton Fair: Rising Demand for At-Home Healthcare Spurs Innovation in…
The company's founder noted that the Canton Fair marks the first public debut of their products. The decision to showcase them at this global platform was driven by the scale of need it seeks to address, with more than 12 million people worldwide suffering a stroke each year, including over 4 million in China and around 8 million elsewhere. The founder expressed hope that the fair would open doors to overseas channel partners interested in innovative healthcare solutions. Through such…
PR Newswire
06/11/2025
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
The patient, diagnosed with chylomicronemia, had a long history of fasting triglyceride (TG) levels exceeding 12.5 mmol/L and recurrent acute pancreatitis. In the dose-escalation IIT for CS-121, his fasting TG level dropped significantly within three days after a single low-dose administration, with no adverse events. The patient, diagnosed with chylomicronemia, had a long history of fasting triglyceride (TG) levels exceeding 12.5 mmol/L and recurrent acute pancreatitis. In the…
PR Newswire
06/11/2025
Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and…
Rheumatoid Arthritis Market Summary Rheumatoid Arthritis Market Summary Discover the rheumatoid arthritis new treatment @New Treatments for Rheumatoid Arthritis Key Factors Driving the Growth of the Rheumatoid Arthritis Market Rising Rheumatoid Arthritis Disease Prevalence According to DelveInsight's estimates, the US accounted for around~1.3 milliondiagnosed prevalent cases of rheumatoid arthritis in 2024. These cases are further expected to increase by 2034...
PR Newswire
05/11/2025
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved…
Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on percentage weight loss onlyBody mass index (BMI) and waist-to-height ratio (a measurement of unhealthy waist size) represent important obesity treatment targets, associated with a lower risk of obesity-related complicationsA study of people with obesity (STEP UP trial) showed that more people taking Wegovy ®achieved a BMI under 27 and a waist-to-height ratio of less than 0...
Nasdaq GlobeNewswire
05/11/2025
Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates…
– 3Q25 total revenues increased 7% year-over-year driven by robust growth of Epidiolex®, Xywav® and the launch of Modeyso – – 3Q25 total revenues increased 7% year-over-year driven by robust growth of Epidiolex® , Xywav® and the launch ofModeyso– DUBLIN , Nov. 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2025 and updated financial guidance for 2025. "Achieving the highest revenue quarter in...
PR Newswire
05/11/2025
Galapagos Reports Nine Months 2025 Financial Results and Provides Business…
Strategic review process concluded with intention to wind down cell therapy business, representing optimal capital allocation pathway to support a stronger and sustainable future for GalapagosContinued evolution of leadership team aligned with strategic direction Robust balance sheet with €3.05 billion in cash and financial investments as of September 30, 2025; year-end 2025 cash position expected at €2.975 billion to €3.025 billion Management to host a ...
Nasdaq GlobeNewswire
05/11/2025
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare…
Media ReleaseCOPENHAGEN, Denmark; November 5, 2025 Genmab A/S (Nasdaq:GMAB)announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London at 12:00 PM GMT(7:00AM EST)on November 19 , 2025 . A webcast of the fireside chat will be available on Genmab’s website athttps://ir.genmab...
Nasdaq GlobeNewswire
05/11/2025
VALNEVA Declaration of shares and voting rights: October 31, 2025
VALNEVADeclaration of shares and voting rightsOctober 31, 2025__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: November 5, 2025 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
05/11/2025
Holistic Luxury Meets Heritage: India's Swastik Wellbeing unveils its Ancient…
The Swastik leadership team believes that India has always been the cradle of healing and conscious living. "The global traveller today seeks wellbeing across five dimensions of Health, Wealth, Love, Bliss and Spirituality. Swastik represents India's evolution as a conscious luxury destination, where wellbeing is lived, felt and culturally rooted," said Ms. Anushree Nyati, Director, Swastik Wellbeing. The Swastik leadership team believes thatIndiahas always been the cradle of healing…
PR Newswire
05/11/2025
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific…
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular risk – including chronic kidney diseaseAllschwil, Switzerland – November 05, 2025Idorsia Ltd (SIX: IDIA) shares that new analysis of the landmark Phase 3 PRECISION study of aprocitentan, Idorsia’s endothelin receptor antagonist, will be presented at theAmerican Society of Nephrology (ASN) Kidney Week 2025, taking place in Houston,...
Nasdaq GlobeNewswire
05/11/2025
Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary…
"Patients on Aspaveli/Empaveli maintained proteinuria reduction, irrespective of taking immunosuppressants and independent of their baseline proteinuria levels. One third of patients achieved complete proteinuria remission compared to 3% for placebo at week 26. These benefits were maintained through one year, and patients who switched from placebo experienced similar improvements. This demonstrates the potential of Aspaveli/Empaveli to transform care for people living with these rare…
PR Newswire
05/11/2025
Hyaluronic Acid Products Market to Reach $20 billion, Globally, by 2034 at 7.7%…
Market Introduction Market Introduction The hyaluronic acid (HA) products market involves a broad range of therapeutic and aesthetic applications derived from hyaluronic acid, a naturally occurring polysaccharide known for its hydration and tissue-repair properties. HA products include dermal fillers, osteoarthritis injections, ophthalmic solutions, wound care formulations, nasal sprays, and drug delivery systems. The market has gained significant momentum due to increasing demand for...
PR Newswire
05/11/2025
Ophthalmic Equipment Market worth US$26.14 billion by 2030 with 5.9% CAGR |…
Browse in-depth TOC on "Ophthalmic Equipment Market" Browse in-depth TOC on "Ophthalmic Equipment Market" 350 - Tables50 - Figures400 - Pages By technology,non-AI-enabled equipment holds the largest market share in the ophthalmic equipment market because of its widespread availability, lower cost, and established clinical reliability. These systems are widely used across hospitals and clinics, requiring minimal technical expertise and maintenance. Additionally, slower...
PR Newswire
05/11/2025
Diaper Rash Cream Market to Reach $4.0 Billion, Globally, by 2033 at 5.8% CAGR…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A10633 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A10633 Prime determinants of growth The global diaper rash cream market is experiencing growth due to several factors such as increasing awareness of skin health in infants and adults and advancements in product formulations and organic options. However, high product costs and...
PR Newswire
05/11/2025
Andor Health's Agentic AI Platform, ThinkAndor®, Receives Frost & Sullivan's…
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: transformational innovation and customer impact. Andor Health excels in both, demonstrating its ability to align strategic initiatives with market demand and execute them efficiently, consistently, and at scale. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: transformational innovation and customer impact. Andor Health excels…
PR Newswire
05/11/2025
Altri Comunicati
